LncRNA PVT1: as a therapeutic target for breast cancer.
Baljon KJ, Ramaiah P, Saleh EAM, Al-Dolaimy F, Al-Dami FH, Gandla K, Alkhafaji AT, Abbas AHR, Alsaalamy AH, Bisht YS.
Baljon KJ, et al. Among authors: ramaiah p.
Pathol Res Pract. 2023 Aug;248:154675. doi: 10.1016/j.prp.2023.154675. Epub 2023 Jul 6.
Pathol Res Pract. 2023.
PMID: 37531833
Review.